Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Value Health. 2010 Oct 15;13(8):893–902. doi: 10.1111/j.1524-4733.2010.00763.x

Figure 2.

Figure 2

Projected pharmaceutical costs (in millions) to US discretionary programs under current practice and expanded screening, 2009-2013, compared to current ADAP budget.